Third-Party Tested ≥98% HPLC Purity — USA Shipped

Research Comparison

MOTS-C vs NAD+

In Short

MOTS-C is mitochondrial-derived peptide; NAD+ is pyridine dinucleotide redox coenzyme / enzyme cosubstrate (sirtuin, parp, cd38 substrate). Both are supplied as lyophilized powders for laboratory and in-vitro research use only. The table below compares their molecular data, half-life and research focus side by side.

MOTS-C NAD+
Classification Mitochondrial-derived peptide Pyridine dinucleotide redox coenzyme / enzyme cosubstrate (sirtuin, PARP, CD38 substrate)
Molecular formula C101H152N28O22S2 C21H27N7O14P2
Molecular weight 2174.64 g/mol 663.43 g/mol
CAS number 1627580-64-6
Research half-life Short circulating half-life in preclinical models Not well characterized; NAD+ undergoes rapid enzymatic turnover and hydrolytic degradation rather than having a single defined pharmacologic half-life
Primary research focus Glucose regulation and insulin sensitivity Aging and metabolic health studies
Form Lyophilized powder Lyophilized powder
Price from $59.00 $67.50

MOTS-C

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S rRNA gene. Its primary mechanism of action involves activation of the AMPK pathway, which regulates cellular energy homeostasis by promoting glucose uptake and fatty acid oxidation independent of insulin signaling. Research published by Lee et al. (Cell Metabolism, 2015) demonstrated that MOTS-c use in diet-induced obese mice significantly improved glucose tolerance and reduced fat accumulation without altering food intake. Subsequent studies from the same USC laboratory showed that MOTS-c levels decline with age in human plasma, and that exercise increases circulating MOTS-c levels, suggesting it functions as a mitochondrial-derived exercise mimetic. Unlike traditional metabolic peptides that target specific membrane receptors, MOTS-c is unique in that it translocates to the nucleus under metabolic stress to regulate nuclear gene expression, particularly genes involved in the methionine-folate cycle and de novo purine biosynthesis. Compared to other mitochondrial-derived peptides like humanin, MOTS-c appears more specifically involved in metabolic regulation rather than cytoprotection. The lyophilized peptide should be stored at -20C and protected from light; reconstitute with bacteriostatic water and store reconstituted solutions at 2-8C for up to 21 days. MOTS-c is primarily researched by aging biology laboratories, exercise physiology departments, and mitochondrial medicine research centers investigating metabolic signaling peptides.

Full MOTS-C research guide

NAD+

NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme present in every living cell, serving as a critical electron carrier in metabolic redox reactions including glycolysis, the citric acid cycle, and oxidative phosphorylation. Beyond energy metabolism, NAD+ functions as a substrate for sirtuins (SIRT1-7), poly(ADP-ribose) polymerases (PARPs) involved in DNA repair, and CD38/CD157 ectoenzymes involved in calcium signaling. NAD+ levels decline significantly with age, and this decline has been implicated as a driver of metabolic dysfunction and cellular senescence. Seminal research by Imai and Guarente (2014) in Trends in Cell Biology established the NAD+ depletion theory of aging, demonstrating that declining NAD+ levels impair sirtuin activity and mitochondrial function. Studies by Yoshino et al. (2011) in Cell Metabolism showed that NAD+ precursor supplementation restored metabolic function in aged and diet-induced obese mice. Research in Science by Li et al. demonstrated that NAD+ repletion improved muscle stem cell function and extended lifespan in aged murine models through SIRT1-dependent mechanisms. This 500mg formulation provides a direct NAD+ supply for research applications. Compared to precursors like NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside), which require enzymatic conversion, direct NAD+ bypasses biosynthetic pathway bottlenecks, though its larger molecular size presents different cellular uptake considerations. Each approach offers distinct advantages depending on the research model. Store lyophilized NAD+ at -20°C, protected from light and moisture, as it is hygroscopic. Reconstitute with bacteriostatic water and store at 2-8°C, using within 2-3 weeks, as NAD+ is susceptible to hydrolytic degradation in solution. NAD+ is studied by aging researchers, metabolic scientists, DNA repair biologists, and mitochondrial function specialists.

Full NAD+ research guide

Frequently Asked Questions

What is the main difference between MOTS-C and NAD+?
MOTS-C is classified as mitochondrial-derived peptide, while NAD+ is pyridine dinucleotide redox coenzyme / enzyme cosubstrate (sirtuin, parp, cd38 substrate). They are distinct research compounds with different mechanisms — the comparison table above sets out the molecular and pharmacokinetic differences side by side.
Can MOTS-C and NAD+ be studied together?
Some research protocols evaluate related peptides in combination, and research blends exist. Combination study design depends entirely on the research question and model. Both compounds are supplied for laboratory and in-vitro research use only — not for human use.
Are MOTS-C and NAD+ legal to buy for research?
Both are sold in the United States as research chemicals for laboratory and in-vitro use only. Neither is FDA-approved for human use. Researchers are responsible for compliance with all applicable regulations.

Buy MOTS-C

From $59.00 — ≥98% HPLC, COA included.

Buy NAD+

From $67.50 — ≥98% HPLC, COA included.

Research Use Only. This comparison summarizes published research. It is not medical advice. Neither compound is for human consumption or FDA-approved.